Oncology Central

State-of-the art advances in fertility preservation for the male cancer patient

0

In an era in which 80% of children and young adolescents who are diagnosed with cancer will survive and achieve cure, male fertility preservation is no longer considered a luxury, but a part of the therapeutic intervention and the standard of care. According to the American Society of Clinical Oncology (ASCO) guidelines 2013, as a component of patient education and an informed consent before cancer therapy, healthcare providers should address the gonadotoxic effect of cancer treatments, and discuss fertility preservation methods with patients prior to the onset of therapy [1].

To view restricted content, please:
Share:

Leave A Comment